Header

UZH-Logo

Maintenance Infos

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials


Hofer, S; Elandt, K; Greil, R; Hottinger, A F; Huber, U; Lemke, D; Marosi, C; Ochsenbein, A; Pichler, J; Roelcke, U; Weder, P; Zander, T; Wick, W; Weller, M (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncologica, 50(5):630-635.

Abstract

Our data reveal valuable palliation with preservation of KPS and an option for steroid withdrawal in patients treated with BEV, supporting the role of this therapy in late-stage disease.

Abstract

Our data reveal valuable palliation with preservation of KPS and an option for steroid withdrawal in patients treated with BEV, supporting the role of this therapy in late-stage disease.

Statistics

Citations

30 citations in Web of Science®
31 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 14 Nov 2011
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2011
Deposited On:14 Nov 2011 13:37
Last Modified:05 Apr 2016 15:04
Publisher:Taylor & Francis
ISSN:0284-186X
Publisher DOI:https://doi.org/10.3109/0284186X.2011.572913
PubMed ID:21495907

Download